World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
22363
World Ranking
17582
National Ranking
8791

Paul F. Mansfield publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul F. Mansfield sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 348 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul F. Mansfield D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul F. Mansfield sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul F. Mansfield is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their primary research contributions lie within the field of Medicine, with a focus on several subfields including Pulmonary and Respiratory Medicine, Surgery, Gastroenterology, Emergency Medicine, and Reproductive Medicine.

Their work often addresses key topics such as Gastric Cancer Management and Outcomes, Intraperitoneal and Appendiceal Malignancies, Metastasis and carcinoma case studies, Gastrointestinal Tumor Research and Treatment, Esophageal Cancer Research and Treatment, Appendicitis Diagnosis and Management, and Esophageal and GI Pathology.

Selected recent publications illustrate the scope of their research interests:

  • Hereditary diffuse gastric cancer: updated clinical practice guidelines, 2020, The Lancet Oncology
  • Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma, 2021, Cancer Discovery
  • Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma, 2020, World Journal of Surgical Oncology
  • Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma, 2021, Annals of Surgery
  • Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma, 2020, Annals of Surgical Oncology

Frequent coauthors who have collaborated with Paul F. Mansfield include:

  • Naruhiko Ikoma
  • Brian D. Badgwell
  • Jaffer A. Ajani
  • Keith F. Fournier
  • Bruce D. Minsky

Paul F. Mansfield's research has been published extensively across several academic journals. The most frequent publication venues are:

  • Annals of Surgical Oncology
  • Journal of Clinical Oncology
  • Gastric Cancer
  • Journal of Surgical Oncology
  • Journal of Gastrointestinal Surgery

Best Publications

  • Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

    Jeffrey E. Gershenwald;William Thompson;Paul F. Mansfield;Jeffrey E. Lee

  • Complications and failures of subclavian-vein catheterization.

    Paul F. Mansfield;David C. Hohn;Bruno D. Fornage;Mary Ann Gregurich

  • Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.

    Issam I. Raad;David C. Hohn;B. Joyce Gilbreath;Nabil Suleiman

  • Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

    Jeffrey E. Gershenwald;Maria I. Colome;Jeffrey E. Lee;Paul F. Mansfield

  • Multi-Institutional Trial of Preoperative Chemoradiotherapy in Patients With Potentially Resectable Gastric Carcinoma

    Jaffer A. Ajani;P. F. Mansfield;N. Janjan;J. Morris

  • Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Charles A. Schiffer;Pamela B. Mangu;James C. Wade;Dawn Camp-Sorrell

  • Ethnic Differences Among Patients With Cutaneous Melanoma

    Janice N. Cormier;Yan Xing;Meichun Ding;Jeffrey E. Lee

  • Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

    Antonio C. Buzaid;Merrick I. Ross;Charles M. Balch;Seng-jaw Soong

  • Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model.

    Y.D. Jung;P.F. Mansfield;M. Akagi;A. Takeda

  • Hereditary Diffuse Gastric Cancer: Updated Clinical Practice Guidelines

    Vanessa R. Blair;Maybelle McLeod;Fátima Carneiro;Daniel G. Coit

  • Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient Outcome

    Jaffer A. Ajani;P. F. Mansfield;C. H. Crane;T. T. Wu

  • Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.

    Andrew M. Lowy;Paul F. Mansfield;Steven D. Leach;Richard Pazdur

  • Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma

    Jeffrey E. Gershenwald;Paul F. Mansfield;Jeffrey E. Lee;Merrick I. Ross

  • Phase II trial of imatinib mesylate in patients with metastatic melanoma

    K B Kim;O Eton;D W Davis;M L Frazier

  • Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group trial Z0020

    Wendy R. Cornett;Linda M. McCall;Rebecca P. Petersen;Merrick I. Ross

  • Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric Cancer

    James C Yao;Liwei Wang;Daoyan Wei;Weida Gong

  • Laparoscopic staging for gastric cancer

    Andrew M. Lowy;Paul F. Mansfield;Steven D. Leach;Jaffer Ajani

  • Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With Melanoma

    Jeffrey E. Gershenwald;Robert H.I. Andtbacka;Victor G. Prieto;Marcella M. Johnson

  • Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.

    Timothy M. Pawlik;Merrick I Ross;Marcella M. Johnson;Christopher W. Schacherer

  • Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

    Dennis L. Rousseau;Merrick I. Ross;Marcella M. Johnson;Victor G. Prieto

Frequent Co-Authors

Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Merrick I. Ross
Merrick I. Ross The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Janice N. Cormier
Janice N. Cormier The University of Texas MD Anderson Cancer Center
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Michael J. Overman
Michael J. Overman The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Cathy Eng
Cathy Eng Vanderbilt University
Christopher H. Crane
Christopher H. Crane Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering studying Medicine or seeking alternative routes into healthcare, a range of online nursing programs in the USA offer accessible pathways. Many students opt for the flexibility and cost savings of remote study, especially if they are balancing work and other responsibilities.

Aspiring nurses can find some of the cheapest phd nursing programs online, making advanced education more affordable than ever. If you already hold an RN license, look for the cheapest rn to bsn online degrees to further your qualifications at a lower cost.

For non-nurses holding a bachelor’s degree in another field, direct entry msn programs offer a fast-track to a nursing career, helping you enter the profession without prior experience. Entry requirements and competitiveness can vary by school and program type.

If you are seeking a more accessible route, research the easiest bsn program to get into to increase your chances of admission. With these options, students can tailor their medical career path based on their educational background, goals, and financial considerations.

Best Scientists Citing Paul F. Mansfield

Trending Scientists

Recently Published Articles